These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4462469)

  • 41. Active basal immunity and its application to epidemiology. I. General considerations.
    ERICSSON H; HESSELVIK L; VAHLQUIST B
    Acta Paediatr (Stockh); 1953 Nov; 42(6):540-1. PubMed ID: 13113934
    [No Abstract]   [Full Text] [Related]  

  • 42. Protective immunity to amebic infection demonstrated in guinea pigs.
    Krupp IM
    Am J Trop Med Hyg; 1974 May; 23(3):355-60. PubMed ID: 4363038
    [No Abstract]   [Full Text] [Related]  

  • 43. [Induction of protective anti-ameba immunity with new antigens in the suckling hamster. d. Histopathology].
    Martínez-Palomo A
    Arch Invest Med (Mex); 1978; 9 Suppl 1():321-4. PubMed ID: 697478
    [No Abstract]   [Full Text] [Related]  

  • 44. [Induction of protective anti-ameba immunity with new antigens in the suckling hamster. c. Technics used; macroscopic lesions].
    Tanimoto M
    Arch Invest Med (Mex); 1978; 9 Suppl 1():315-9. PubMed ID: 697477
    [No Abstract]   [Full Text] [Related]  

  • 45. Experimental induction of protective immunity to amebic infection.
    Krupp IM
    Arch Invest Med (Mex); 1974; 5 SUPPL 2():415-22. PubMed ID: 4462469
    [No Abstract]   [Full Text] [Related]  

  • 46. Amebiasis: host-pathogen biology.
    Sepúlveda B
    Rev Infect Dis; 1982; 4(6):1247-53. PubMed ID: 6296964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmonella: immune responses and vaccines.
    Mastroeni P; Chabalgoity JA; Dunstan SJ; Maskell DJ; Dougan G
    Vet J; 2001 Mar; 161(2):132-64. PubMed ID: 11243685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective immunity to amebiasis: new insights and new challenges.
    Stanley SL
    J Infect Dis; 2001 Aug; 184(4):504-6. PubMed ID: 11471109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent progress in vaccines for amebiasis.
    Snow MJ; Stanley SL
    Arch Med Res; 2006 Feb; 37(2):280-7. PubMed ID: 16380333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active and passive immunity, vaccine types, excipients and licensing.
    Baxter D
    Occup Med (Lond); 2007 Dec; 57(8):552-6. PubMed ID: 18045976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.